Dynamic Technology Lab Private Ltd Lowers Stock Position in Bath & Body Works, Inc. $BBWI

Dynamic Technology Lab Private Ltd cut its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 70.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,286 shares of the company’s stock after selling 71,754 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Bath & Body Works were worth $908,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Bath & Body Works during the second quarter worth about $33,000. SVB Wealth LLC purchased a new position in shares of Bath & Body Works during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. boosted its position in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC increased its position in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in Bath & Body Works by 24.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after buying an additional 364 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

BBWI has been the topic of a number of recent research reports. Bank of America cut their target price on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Thursday. Citigroup cut their price objective on shares of Bath & Body Works from $35.00 to $21.00 and set a “buy” rating on the stock in a research report on Friday. Robert W. Baird restated a “neutral” rating and set a $19.00 price objective (down from $33.00) on shares of Bath & Body Works in a research note on Thursday. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $18.00 price target (down previously from $43.00) on shares of Bath & Body Works in a report on Friday. Seven research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $26.90.

Bath & Body Works Stock Down 6.2%

Shares of Bath & Body Works stock opened at $14.84 on Friday. The company has a market cap of $3.06 billion, a price-to-earnings ratio of 4.40, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. The company’s 50 day moving average is $24.58 and its 200 day moving average is $28.14. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company’s revenue for the quarter was down 1.0% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 5.4%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio is 24.62%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.